Erez Israeli, chief executive officer of Dr. Reddy's Laboratories, an Indian multinational pharmaceutical company, has confirmed that he will participate in the sixth China International Import Expo and the sixth Hongqiao International Economic Forum this November.

Erez Israeli, chief executive officer of Dr. Reddy's Laboratories. [Photo/CIIE Bureau]

"The CIIE is a global trade event and an international platform for win-win cooperation," said Israeli.

A first-time participant of the expo, Dr. Reddy's will showcase its wide range of products, including generics, patented products, biosimilars, and foods for special medical purposes (FSMPs), at this year's expo, according to Israeli.

Founded in 1984, Dr. Reddy's has a portfolio of over 400 products and a business presence in more than 70 countries.

Since entering the Chinese market in 2000, the company has consistently introduced affordable pharmaceuticals spanning areas including oncology, diabetes, central nervous system disorders, and cardiovascular diseases.

By Zhao Guangmei